News Column

HOLOGIC INC FILES (8-K) Disclosing Regulation FD Disclosure, Financial Statements and Exhibits

February 13, 2014



Item 7.01 Regulation FD Disclosure.

Hologic, Inc. ("Hologic" or the "Company") is seeking to amend its senior secured credit facilities in conjunction with a proposed refinancing (the "Credit Facility Refinancing") of its existing secured tranche B term loan with a final maturity date of August 1, 2019 (the "Term Loan B"). As of February 12, 2014, the outstanding principal amount of the Term Loan B was $1.18 billion. A meeting is scheduled between senior officers of the Company and prospective lenders to be held on February 13, 2014 related to the Credit Facility Refinancing. The terms of the Credit Facility Refinancing are expected to include a reduction in the interest rates on the Term Loan B. The Credit Facility Refinancing and contemplated amendments are subject to market and other conditions, including obtaining the requisite consent of the lenders. The Company cannot assure that such Credit Facility Refinancing will be completed on the terms contemplated, or on a timely basis, if at all.

Attached hereto as Exhibit 99.1 are certain slides from an investor presentation that the Company plans to present to its lenders for the Credit Facility Refinancing.

Limitation on Incorporation by Reference. The information furnished in this Item 7.01, including the investor presentation attached hereto as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Cautionary Note Regarding Forward-Looking Statements. Except for historical information contained in the investor presentation attached as an exhibit hereto, the investor presentation contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary notes above and in the investor presentation regarding these forward-looking statements.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. Exhibit Number Description 99.1 Investor presentation.



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools